These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 40798)
41. Antianginal and haemodynamic effects of a new beta-blocking agent, SD 1601. Radice M; Folli G; Tavecchia A; Mariotti G; Cameroni E Arzneimittelforschung; 1978; 28(11):2160-3. PubMed ID: 40567 [TBL] [Abstract][Full Text] [Related]
42. Cardio-protection afforded by β-blockade is maintained during resistance exercise. Conviser JM; Ng AV; Rockey SS; Thomas DP J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728 [TBL] [Abstract][Full Text] [Related]
43. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers. Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164 [TBL] [Abstract][Full Text] [Related]
44. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
45. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris. Heterington DJ; Comerford MB; Nyberg G; Besterman EM Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566 [No Abstract] [Full Text] [Related]
46. [Metoprolol effect on ECG exercise test in patients with stable angina pectoris. Computer analysis (author's transl)]. Manca C; Bruno G; Burani F; Dei Cas L; Percoco G; Scarfò S G Ital Cardiol; 1979; 9(10):1104-9. PubMed ID: 261957 [TBL] [Abstract][Full Text] [Related]
47. Effects of different beta-receptor antagonists on handgrip in essential hypertension. Fogari R; Marchesi E; Bellomo G; Parini A; Corradi L Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200 [TBL] [Abstract][Full Text] [Related]
48. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests. Bjerle P; Jacobsson KA Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804 [No Abstract] [Full Text] [Related]
49. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris. Keyriläinen O; Uusitalo A Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388 [TBL] [Abstract][Full Text] [Related]
50. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests. Keyriläinen O; Uustialo A Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092 [TBL] [Abstract][Full Text] [Related]
51. Comparison of intra-arterial and indirect blood pressures at rest and during isometric exercise in hypertensive patients before and after metoprolol. Hunyor S; Nyberg G Br J Clin Pharmacol; 1978 Aug; 6(2):109-14. PubMed ID: 678386 [TBL] [Abstract][Full Text] [Related]
52. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. Gullestad L; Hallen J; Medbø JI; Grønnerød O; Holme I; Sejersted OM Br J Clin Pharmacol; 1996 Jan; 41(1):57-67. PubMed ID: 8824694 [TBL] [Abstract][Full Text] [Related]
53. Alprenolol alone and in conjunction with pentanitrol in angina pectoris. A double-blind study with exercise tests. Hansen PF; Rasmussen PA; Nyberg G Acta Med Scand; 1973 May; 193(5):419-24. PubMed ID: 4197873 [No Abstract] [Full Text] [Related]
54. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade. Sheridan DJ; Thomas P; Culling W; Collins P J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S144-50. PubMed ID: 2423788 [TBL] [Abstract][Full Text] [Related]
55. Alpha- and beta-blockade in angina pectoris. Taylor SH Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892 [TBL] [Abstract][Full Text] [Related]
56. Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris. Dwyer EM; Pepe AJ; Pinkernell BH Am Heart J; 1982 May; 103(5):830-3. PubMed ID: 6803556 [TBL] [Abstract][Full Text] [Related]
57. Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test. A double-blind, randomized subacute study. Ekelund LG; Orö L Clin Cardiol; 1979 Jun; 2(3):203-11. PubMed ID: 389513 [TBL] [Abstract][Full Text] [Related]
58. The effects of alpha- and beta-adrenergic receptor blockers on the pressure responses to isometric exercise in hypertensive patients. Reuben SR; Gale EV; Blake P Br J Clin Pharmacol; 1979 Oct; 8(4):365-8. PubMed ID: 41550 [TBL] [Abstract][Full Text] [Related]
59. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol. Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524 [TBL] [Abstract][Full Text] [Related]
60. Effect of chronic atenolol therapy on the cardiovascular response to handgrip in hypertensive patients. Orlandi C; Fogari R Clin Ther; 1983; 5(6):632-7. PubMed ID: 6627289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]